| Literature DB >> 26367388 |
Maxime Wack1, Etienne Puymirat2, Brigitte Ranque3, Sophie Georgin-Lavialle4, Isabelle Pierre5, Aurelia Tanguy6, Felix Ackermann4, Celine Mallet4, Juliette Pavie7, Hakima Boultache1, Pierre Durieux8, Paul Avillach9.
Abstract
OBJECTIVE: To evaluate the impact of computerized provider order entry (CPOE) at the bedside on medical students training.Entities:
Mesh:
Year: 2015 PMID: 26367388 PMCID: PMC4569055 DOI: 10.1371/journal.pone.0138094
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Cross-over schema and distribution of subjects.
| Quarter | Intervention | Department | CR | Students |
|---|---|---|---|---|
| 1 | Control | Cardio | 2 | 2 |
| 1 | Control | Int Med | 2 | 4 |
| 1 | Case | Int Med | 2 | 5 |
| 1 | Case | Immuno | 1 | 7 |
| 2 | Case | Cardio | 3 | 3 |
| 2 | Case | Int Med | 2 | 5 |
| 2 | Control | Int Med | 2 | 3 |
| 2 | Control | Immuno | 1 | 7 |
Fig 1Density plot of the overall questionnaire progress between the beginning and the end of the rotation, for each group.
Controls are represented with a continuous line, Cases with a dotted line.
Fig 2Scatterplots of the progress of the students on each item of the questionnaire between the beginning and the end of the rotation.
Plots are shown with one row for each chief resident, left column for the Control group, and right column for the Case group. Item scores have been normalized. A smoothed estimator is fitted for each subplot.
Fig 3Boxplots of the progress distribution on all questionnaire items for each (a) chief resident, (b) intervention group, (c) student.
Representative items in decreasing order of loading for each of the four dimensions.
|
| III_7: I am receiving adequate preparation for being an intern |
|
| III_4: My chief resident thought it was important for me to have x |
|
| III_2: I was included in discussions about the management of my patients |
|
| IV_1 (negative): Resident or intern did not want me to write or enter orders |
|
| II_1: During this rotation, what was, in your opinion, your contribution to the medical care of patients? |
|
| I_2: Placing orders is an important way to learn what tests and treatments are needed by patients with certain problems |
|
| I_1: Placing orders is an important way to increase my sense that I am a caregiver for my patients |
|
| V_3: What percentage of your patients total number of admission and follow-up orders would you like to review with your supervisor |
|
| I_9: Medical students should be given as many opportunities as possible to place orders |
|
| I_10 (negative): The ordering method used will have an impact on my selection of the location of my future rotations |
|
| V_1: For what percent of newly admitted patients that you picked up have you entered the complete set of admission orders? |
|
| IV_10 (negative): Computer ordering system difficult to use |
|
| I_5: Writing orders by hand encourages medical errors |
|
| I_7 (negative): Entering computerized orders encourages medical errors |
|
| IV_4–6: It took too long for the resident/chief resident/other senior to review the orders I wrote |
|
| IV_9: Inadequate training on the computer ordering system |
|
| IV_7: Difficulty in finding a free computer terminal |
Comparison of dimension scores between the case and control groups.
| Control group | Case group | p value | |||
|---|---|---|---|---|---|
| Dimension | Mean | SD | Mean | SD | |
| Overall satisfaction (14 items) | 6.6 | 2.8 | 8.4 | 3.1 | 0.035* |
| Opinion about prescribing (7 items) | 4.2 | 1.5 | 5.1 | 1.2 | 0.057 |
| Opinion about CPOE (8 items) | 3.1 | 0.8 | 4.3 | 1 | <0.001* |
| Difficulties with CPOE (6 items) | 1.3 | 1.3 | 2.4 | 1.6 | 0.019* |
Drug order errors corrected by Chief Residents.
| Type of modification by the supervisor of erroneous orders | Number |
|---|---|
| Cancellation | 9 |
| Modification of dose | 7 |
| Modification of treatment duration | 5 |
| Modification of drug in the same therapeutic class | 5 |
| Modification of the time of delivery | 4 |
| Modification of the route of administration and dose (intravenous) | 3 |
| Modification of the time of delivery and dose | 3 |
| Modification of dose and treatment duration | 2 |
| Modification de the time of delivery and dose (intravenous) | 2 |
| Modification of the route of administration | 2 |
| Modification of drug in another therapeutic class | 2 |
| No modification | 2 |
| Cancellation because it was already prescribed | 2 |
| Modification of individual doses without changing the daily dose | 1 |
|
|
|